Abdominal Regional Fat Distribution on MRI Correlates with Cholecystolithiasis

Abstract

Aims

To determine whether abdominal regional fat distribution pattern on MRI is correlated with cholecystolithiasis.

Methods

Magnetic resonance imaging (MRI) of 163 patients with cholecystolithiasis and 163 non-cholecystolithiasis control subjects admitted to our institution between March 2011 and September 2013 were included in this cross-sectional evaluation. There were 98 women and 65 men in cholecystolithiasis group with an average age of 57±16 years (range 25–86 years). There were 87 women and 76 men in the control group with an average age of 41±16 years (range 14–77 years). Visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT) and total abdominal adipose tissue (TAT) of all the subjects at navel level were measured on abdominal MRI. According to the visceral adipose area (cut-off point VAT = 100 cm²), study subjects were divided into 1) increased accumulation of intra-abdominal fat and 2) normal distribution of intra-abdominal fat. Logistic regression was used to assess the association of fat with the presence of cholecystolithiasis, adjusted for age and sex.

Results

The incidence of increased intra-abdominal fat accumulation in the cholecystolithiasis group was significantly higher than that of the control group (P = 0.000). After adjusting for age and sex, cholecystolithiasis was associated with a one standard deviation increment in the waist circumference (WC) (OR = 1.44; 95%CI: 1.01,1.93; p = 0.00), VAT (OR = 4.26; 95%CI: 1.85,5.29; p = 0.00), VAT/SAT (OR = 8.66; 95%CI: 1.60,12.63; p = 0.00), and VAT/TAT (OR = 6.73; 95%CI: 4.24,12.18; p = 0.00), but not with fat content in the abdominal subcutaneous fat (p = 0.19).

Conclusions

The visceral adipose tissue and distribution proportion of abdominal adipose tissue are correlates of cholecystolithiasis.

About the Authors:

Yang Zhang

Contributed equally to this work with: Yang Zhang, Tian Wu Chen

Affiliation: Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, China

Tian Wu Chen

Contributed equally to this work with: Yang Zhang, Tian Wu Chen

Affiliation: Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, China

Xiao Ming Zhang

* E-mail: [email protected]

Affiliation: Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, China

Yi-Xiang Wang

Affiliation: Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong SAR, China

Xiao Xiao Chi

Affiliation: Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, China

Xing Hui Li

Affiliation: Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, China

Xiao Feng Gao

Affiliation: Department of Preventive Medicine, North Sichuan Medical College, Nanchong, Sichuan Province, China

Yi Fan Ji

Affiliation: Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Sichuan Province, China

Introduction

Gallstone represents a major disease burden, affecting approximately 10–20% of the U.S. population [1]. In China and some other Asian countries, gallstone disease is also an important public health problem [2], [3]. Cholecystolithiasis is very common and can be divided into symptomatic and asymptomatic clinically. Common complications of gallbladder stone include acute cholecystitis, biliary obstruction, acute pancreatitis and cholangitis. Severe complications of cholecystolithiasis include gallbladder perforation, Mirizzi syndrome and fistula formation, and are usually associated with significant morbidity and mortality [4]–[7]. In addition, cholecystolithiasis is strongly associated with gallbladder cancer and considered an intermediate step in gallbladder cancer pathogenesis [8]. In China, there has been an increase in cholesterol stone and a decrease in pigment stone during the past a few decades [9], probably related to increasing obesity and a more westernized diet (containing more fat) and lifestyle (physically inactive) [10]. A large number of studies also show that overweight and obesity are well-established risk factors for gallstone diseases such as cholecystolithiasis [2], [11]–[14]. Central obesity, measured by waist-to-hip ratio, is independently related to risk for gallstone after taking into account total adiposity, as measured by body mass index (BMI) [15]–[16]. High central obesity and BMI are two independent risk factors for metabolic conditions, such as insulin resistance, reduced number of insulin receptors, and low plasma high-density lipoprotein cholesterol and therefore may play an important role in the etiology of gallstone disease [17]. Similarly, there is a significant association between abdominal adiposity and the incidence of symptomatic gallstone disease [14]. However, whether abdominal regional fat distribution is associated with cholecystolithiasis has not been recorded in the reported studies.

Magnetic resonance imaging (MRI) can accurately quantify the volumes of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) [18]–[20]. This study investigated whether distribution characteristics and the quantity of abdominal adipose tissue measured by MRI are associated with cholecystolithiasis.

Subjects and Methods

1 Study population

This study was approved by our institutional review board and the Ethics Committee of Affiliated Hospital of North Sichuan Medical College. Because of the retrospective nature of this study and the informed consent was waived. The study complies with the ethical principles of the Helsinki Declaration of 1964, revised by the World Medical Organization in Edinburgh in 2000. Inpatients with cholecystolithiasis from March 2011 to September 2013 in our hospital who had abdominal MRI were candidates of this study. Non-cholecystolithiasis patients who had abdominal MRI during the same period were used as control subjects.

The inclusion criteria for cholecystolithiasis group were as follows: (1) cholecystolithiasis was confirmed by surgery and pathology; (2) Abdominal MRI was performed after admission and 1 week before surgery and image quality met diagnostic requirements.

For the control group, the inclusion criteria were as follows: (1) US or CT showed no cholecystolithiasis in the patients (2) Abdominal of MRI was performed after admission and showed no cholecystolithiasis. (3) Adipose tissue was displayed clearly on MRI.

The exclusion criteria for both cholecystolithiasis group and non-cholecystolithiasis control group included conditions which can cause the redistribution of the body fat, such as history of chronic consumptions disease, history of using cortical hormone. Finally, 163 patients with cholecystolithiasis and 163 non-cholecystolithiasis control subjects were included in this study. There were 98 women and 65 men in cholecystolithiasis group with an average age of 57±16 years (range 25–86 years). There were 87 women and 76 men in the control group with an average age of 41±16 years (range 14–76 years).

2 MRI techniques

All MR images were obtained with a 1.5T whole body scanner (Signa, GE Medical Systems, Milwaukee, WI, USA). The general MRI sequences for abdomen included: transverse gradient echo T1-weighted image (GRE T1WI); cross-sectional respiratory triggered axial fast recovery fast spin-echo T2-weighted image (FRFSE T2WI); coronal and cross-sectional single shot fast spin echo T2-weighted image (SSFSE T2WI); double echo chemical displacement fast spoiled gradient echo (FSPGR), in-phase and out-phase obtained using a breath-hold scanning and every breath-hold was about 20 second; single shot fast spin echo MR cholangiopancreatography (MRCP). T1-weighted imaging was performed using GRE sequence with the following parameters: TR 147 ms, TE 1.7 ms, flip angle 80°, Slice thickness 5∼8 mm, Slice space 0.5∼1.0 mm. T2-weighted imaging was performed using FRFSE with the following parameters: TR 10000∼12000 ms, TE 90∼100 ms, Slice thickness 5 mm, Slice space 0.5 mm. The parameters of double echo with in-phase and out-phase T1 weighted were TR 145 ms, flip angle 75°, matrix 256×192, field of view 42 cm×30 cm, Slice thickness 6 mm, Slice space 1 mm, number of excitation (NEX) 1.

3 MR images review

The original MRI data were loaded onto a workstation (Advantage Workstation 4.2; GE Healthcare). The scanning level of navel, L4 or L4/L5 vertebral clearance has been used to study the distribution characteristics of abdominal adipose tissue [21]–[23]. In this study, according to the acquisition of a localizer sequence, the inter-vertebral space between the fourth and fifth lumbar vertebrae was identified by locating the umbilicus [14], [24]–[25].

Based on signals on MR images, the fat area was manually drawn and excluding intestines and big vessels. SAT was defined as the area between outline of abdominal skin and the outer abdominal muscle; VAT was defined as enterocoelia and retroperitoneal region between the inside edge of abdominal muscles and the spinal front. SAT and VAT were divided and measured at navel level on abdominal MRI using area measurement tool (Advantage Workstation 4.2; GE Health-care Technologies, Milwaukee, WI) (Figure 1).

[Figure omitted. See PDF.]

Figure 1. A 52-year-old male with gallbladder stone.

One stone can be found in neck of gallbladder (A) and navel level image was found by a localizer sequence (B). SAT is to be the area between outline of abdominal skin and the outer abdominal muscle (C). VAT is to be enterocoelia and retroperitoneal region between the inside edge of abdominal muscles and the spinal front. Intestines and big vessels that have been circled by green line are not included in the intra-abdominal fat area (D). Axial fast-recovery fast spin-echo T2-weighted images without fat suppression shows intra-abdominal fat with SAT = 96.21 cm² and VAT = 104.05 cm².

https://doi.org/10.1371/journal.pone.0109776.g001

Total abdominal adipose tissue (TAT, TAT = SAT+VAT) and the waist circumference (WC) were also measured and calculated on the images. To examine the reproducibility of the measures of fat depots, the archived scans for the control group were read by 3 different MRI technicians. The technical errors for 3 repeated readings of the same scan by the same observer for SAT and VAT volumes in our laboratory were 0.99% and 1.95% respectively. The intraclass correlation coefficients among the 3 analysts (who each read the same scans twice, separated by a 3-month interval) for SAT and VAT were 0.99 and 0.95 respectively.

4 Statistical analysis

This study used Statistical Package for Social Sciences (SPSS) 13.0 software (Chicago, IL, USA) for statistical analysis. All data are presented as mean and standard deviation or n and %. Differences between the two groups were tested for using the t-test. The prevalence of cholecystolithiasis was recorded in subjects with VAT≥100 cm² and VAT<100 cm². A chi-square test was used for the differences in the prevalence of cholecystolithiasis. Spearman correlation coefficients between fat measures were calculated. Logistic regression was used to assess the association of fat measured with the presence of cholecystolithiasis, adjusting for age and sex. The level of significance was set at P<0.05.

Results

1 Demographic and body-composition characteristics

Demographic characteristics of the study subjects and mean values for fat compartments and distribution proportion of the cholecystolithiasis group and the control group are shown in Table 1. Individuals with cholecystolithiasis were older compared to control groups (p = 0.000). Among 163 subjects with cholecystolithiasis, 98(60%) were female. Among 163 subjects in control group, 87(53%) were female. However, this sex differences had no statistical significance. The values of VAT, WC, VAT/SAT, VAT/TAT, TAT of cholecystolithiasis group were substantially higher than those of the control group and the difference had statistical significance, all P = 0.000. However, the difference of SAT between the cholecystolithiasis group and the controls was no significant (P>0.05).

[Figure omitted. See PDF.]

Table 1. Subject characteristics and adipose tissue distribution.

https://doi.org/10.1371/journal.pone.0109776.t001

2 The comparison of incidence of intra-abdominal fat accumulation on MRI

Asian with VAT≥100 cm² on CT or MRI can be diagnosed with abdominal obesity [26], [27]. According to this standard, all subjects were divided into 1) increased accumulation of intra-abdominal fat, or 2) normal distribution of intra-abdominal fat. The cholecystolithiasis group and control group for the incidence of intra-abdominal fat increased accumulation were compared. The incidence of intra-abdominal fat increased accumulation in the cholecystolithiasis group was significantly higher than that of control group (p = 0.000, Table 2).

[Figure omitted. See PDF.]

Table 2. The incidence of intra-abdominal fat increased accumulation on MRI between the cholecystolithiasis group and the control group.

https://doi.org/10.1371/journal.pone.0109776.t002

3 Degree of correlation between fat measurements

The VAT, TAT, and WC were all strongly correlated, whereas the TAT was highly correlated with VAT. SAT were moderately correlated with WC. On the other hand, the VAT was weakly correlated with SAT (Table 3).

[Figure omitted. See PDF.]

Table 3. Spearman correlation coefficients between abdominal fat measurement on MRI in 326 subjects from the cholecystolithiasis group and the control group.

https://doi.org/10.1371/journal.pone.0109776.t003

4 The relationship of fat measures with cholecystolithiasis

Logistic regression analysis was used to examine the association of abdominal fat with cholecystolithiasis (Table 4). The VAT, WC, VAT/SAT, VAT/TAT were significantly associated with cholecystolithiasis in single factor logistic regression analysis, whereas the association of the SAT with cholecystolithiasis were rendered statistically non-significant (Model 1). The VAT, WC, VAT/SAT, VAT/TAT were significantly associated with cholecystolithiasis after further adjustment of age (all p = 0.000, Model 2). In age-sex-adjusted models, cholecystolithiasis was associated with a one standard deviation increment in the WC (OR = 1.44; 95%CI: 1.01,1.93), VAT (OR = 4.26; 95%CI: 1.85,5.29), ratio of visceral/subcutaneous adipose tissue (VAT/SAT) (OR = 8.66; 95%CI: 1.60,12.63), and ratio of visceral/total abdominal adipose tissue (VAT/TAT) (OR = 6.73; 95%CI: 4.24,12.18).

[Figure omitted. See PDF.]

Table 4. Association of different measurements of abdominal fat and distribution proportion of abdominal adipose tissue with cholecystolithiasis.

https://doi.org/10.1371/journal.pone.0109776.t004

Discussion

In our study, the overall burden of abdominal visceral fat and distribution proportion of abdominal adipose tissue on MRI were strongly associated with cholecystolithiasis. We did not find associations of abdominal subcutaneous fat with cholecystolithiasis. To our knowledge, our study is the first to support the presence of associations of the abdominal visceral fat, distribution proportion of abdominal adipose tissue with cholecystolithiasis.

In a previous report, Tsai et al [20] found that there was significant association between abdominal adiposity and the incidence of symptomatic gallstone disease, but they did not discuss the associations of abdominal fat composition and distribution with cholecystolithiasis. Our results showed that waist circumference, visceral adipose tissue, ratio of visceral adipose tissue/abdominal subcutaneous adipose tissue and ratio of visceral adipose tissue/total abdominal adipose tissue were associated with cholecystolithiasis. As measures of abdominal adiposity, waist circumference and waist-to-hip ratio predict the risk of developing gallstones [14]. Similarly, our study demonstrated that larger waist circumference was associated with cholecystolithiasis.

In recent years, authors from Japan and South Korea confirmed that for Asian CT or MRI study of VAT≥100 cm² can be diagnosed with abdominal obesity [26], [27]. The research of Rankinen et al also confirmed that the VAT cut-off point for visceral abdominal obesity was 100 cm² [28]. According to this standard, in our study all subjects are divided into the intra-abdominal fat increased accumulation group and the normal fat distribution group. Our results showed that the incidence of intra-abdominal fat increased accumulation in patients with cholecystolithiasis was significantly higher than that of in control subjects. Our results confirmed that intra-abdominal fat increased accumulation is associated with cholecystolithiasis, which directly supported to the notion that abdominal or centripetal obesity was associated with gallstone disease [2], [11]–[14]. Though the mechanism by which obesity increases the risk of gallstone diseases is still unclear, a few biologically plausible pathways by which central adiposity may be linked to gallstone formation have been proposed [29], [30]. Obesity, particularly abdominal obesity may be correlated with an increased activity of the rate-limiting step in cholesterol synthesis, the hepatic enzyme, 3-hydroxyl-3-methyl-glutaryl co-enzyme A (HMG-CoA) reductase, leading to increased cholesterol synthesis in the liver and its heightened secretion into bile [31]–[33]. High biliary lipid concentration is a factor for the formation of cholecystolithiasis and gallbladder sludge is thought to be the usual precursor of cholecystolithiasis [34].

The occurrence of gallstones disease is positively related to advancing age, as gallstone is unusual in persons younger than 30 years [35]. Age factor has been previously highlighted in several studies. The frequency of gallstones increases with age, escalating markedly after age 40 to become 4 to 10 times more likely in older individuals [2], [36]. The stone type also changes with age: initially being composed predominantly of cholesterol but in late life tending to be black pigment stones [37]. Similarly, autopsy studies conducted in Sweden and the Czech Republic showed the incidence of gallstones to be 30% in men and 50% in women older than 20 years of age [38]. In this study we also further confirmed age was associated with cholecystolithiasis.

In our study, gender was not associated with cholecystolithiasis. This negative finding may be due to the limited sample size. In fact, it has been previously documented in many studies that being female is the single most important non-modifiable cause of gallstones [37], [39]. In a Pakistan study, 85.4% of their gallstones patients were female [40]. The underlying mechanism is female sex hormones. Estrogen replacement therapy is an established risk factor for cholesterol gallstone formation [41].

Our study has several limitations. Firstly, our study was a cross-sectional study; therefore, no causal inferences can be made. Secondly, this study was a single center study with small sample size. In the future multicenter data and larger sample size should be included. Lastly, we did not assess subjects’ blood biochemical composition of the fat; it is possible that composition measures of adiposity may show the association between cholesterol, high-density lipoprotein and cholecystolithiasis.

In conclusion our data suggest that the overall burden of intra-abdominal fat, but not abdominal subcutaneous fat, is associated with cholecystolithiasis. The distribution proportion of abdominal adipose tissue is also a correlate of cholecystolithiasis. These findings expand our knowledge of body composition in a cohort with cholecystolithiasis, which provides a reference for a longitudinal design study of the relationship between visceral fat tissue and cholecystolithiasis.

Author Contributions

Conceived and designed the experiments: YZ TWC XMZ YXW XXC XHL YFJ. Performed the experiments: YZ XMZ XXC XHL. Analyzed the data: YZ XHL XXC XFG YFJ. Contributed reagents/materials/analysis tools: YZ XXC XHL YFJ. Contributed to the writing of the manuscript: YZ TWC XMZ YXW.

Citation: Zhang Y, Chen TW, Zhang XM, Wang Y-X, Chi XX, Li XH, et al. (2014) Abdominal Regional Fat Distribution on MRI Correlates with Cholecystolithiasis. PLoS ONE 9(10): e109776. https://doi.org/10.1371/journal.pone.0109776

References

1. Bowen JC, Brenner HI, Ferrante WA, Maule WF (1992) Gallstone disease. Pathophysiology, epidemiology, natural history, and treatment options. Med Clin North Am 76: 1143–1157.

2. Shaffer EA (2005) Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 7: 132–140.

3. Shaffer EA (2006) Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20: 981–996.

4. Menakuru SR, Kaman L, Behera A, Singh R, Katariya RN (2004) Current management of gall bladder perforations. ANZ J Surg 74: 843–846.

5. Johnson LW, Sehon JK, Lee WC, Zibari GB, McDonald JC (2001) Mirizzi’s syndrome: experience from a multi-institutional review. Am Surg 67: 11–14.

6. Lee JH, Han HS, Min SK, Lee HK (2004) Laparoscopic repair of various types of biliary-enteric fistula: three cases. Surg Endosc 18: 349.

7. Peer A, Witz E, Manor H, Strauss S (1995) Intrahepatic abscess due to gallbladder perforation. Abdom Imaging 20: 452–455.

8. Wernberg JA, Lucarelli DD (2014) Gallbladder cancer. Surg Clin North Am 94(2): 343–60.

9. Wang W, Wu ZS, Zhao D, Wu GX, Wang WH, et al. (2003) The trends of body mass index and overweight in population aged 25–64 in Beijing during 1984–1999. Zhonghua Liu Xing Bing Xue Za Zhi 24: 272–275.

10. Hou L, Ji BT, Blair A, Dai Q, Gao YT, et al. (2004) Commuting physical activity and risk of colon cancer in Shanghai. China. Am J Epidemiol 160: 860–867.

11. Erlinger S (2000) Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol 12: 1347–1352.

12. Amaral JF, Thompson WR (1985) Gallbladder disease in the morbidly obese. Am J Surg 149: 551–557.

13. Johansen C, Chow WH, Jørgensen T, Mellemkjaer L, Engholm G, et al. (1996) Risk of colorectal cancer and other cancers in patients with gall stones. Gut 39: 439–443.

14. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (2004) Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 80: 38–44.

15. Ruhl CE, Everhart JE (2001) Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease. Hepatology 34: 877–883.

16. Haffner SM, Diehl AK, Stern MP, Hazuda HP (1989) Central adiposity and gallbladder disease in Mexican Americans. Am J Epidemiol 129: 587–595.

17. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, et al. (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 145: 614–619.

18. Ross R, Rissanen J (1994) Mobilization of visceral and subcutaneous adipose tissue in response to energy restriction and exercise. Am J Clin Nutr 60: 695–703.

19. Thomas EL, Saeed N, Hajnal JV, Brynes A, Goldstone AP, et al. (1998) Magnetic resonance imaging of total body fat. J Appl Physiol 85: 1778–1785.

20. Abate N, Garg A, Coleman R, Grundy SM, Peshock RM (1997) Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 65: 403–408.

21. Thomas EL, Bell JD (2003) Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 27: 211–218.

22. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, et al. (1982) Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36: 172–177.

23. Sjöström L, Kvist H (1988) Regional body fat measurements with CT-scan and evaluation of anthropometric predictions. Acta Med Scand 723: 169–177.

24. Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P (1996) Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol 81: 2445–2455.

25. Ross R, Rissanen J, Hudson R (1996) Sensitivity associated with the identification of visceral adipose tissue levels using waist circumference in men and women: effects of weight loss. Int J Obes Relat Metab Disord 20: 533–538.

26. Examination Committee of Criteria for ‘Obesity Disease’ in Japan (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66: 987–992.

27. Jang Y, Kim OY, Ryu HJ, Kim JY, Song SH, et al. (2003) Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J Lipid Res 44: 2356–2364.

28. Rankinen T, Kim SY, Pérusse L, Després JP, Bouchard C (1999) The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes 23: 801–809.

29. Despres JP (2001) Health consequences of visceral obesity. Ann Med 33: 534–541.

30. Grundy SM (2000) Metabolic complications of obesity. Endocrine 13: 155–165.

31. Erlinger S (2000) Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol 12: 1347–1352.

32. Lambou-Gianoukos S, Heller SJ (2008) Lithogenesis and bile metabolism. Surg Clin North Am 88: 1175–1194.

33. Shaffer EA, Small DM (1977) Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 59: 828–840.

34. Njeze GE. Gallstones. Niger J Surg 19: 49–55.

35. Panpimanmas S, Manmee C (2009) Risk factors for gallstone disease in thai population. J Epidemiol 19: 116–121.

36. Einarsson K, Nilsell K, Leijd B, Angelin B (1985) Influence of age on ecretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 313: 277–282.

37. Völzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, et al. (2005) Independent risk factors for gallstone formation in a region with high cholilithiasis prevalence. Digestion 71: 97–105.

38. Zahor A, Sternby NH, Kagan A, Uemura K, Vanecek R, et al. (1974) Frequency of cholilithiasis in prague and malmo. An autopsy study. Scand J Gastroenterol 9: 3–7.

39. Jorgensen T (2005) Epidemiology and gallstones. Ugeskr Laeger 167: 2610–2613.

40. Naeem M, Rahimnajjad NA, Rahimnajjad MK, Khurshid M, Ahmed QJ, et al. (2012) Assessment of characteristics of patients with cholelithiasis from economically deprived rural Karachi, Pakistan. BMC Res Notes 5: 334.

41. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, et al. (2005) Effect of estrogen therapy on gallbladder disease. JAMA 293: 330–339.